Suppression of the development of primary antibacterial immunity by heterologous anti-lymphocyte serum.
D000818:Animals; D000863:Antacids; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001428:Bacterial Vaccines; D004888:Erysipelothrix / Q000276:immunology; D004889:Erysipelothrix Infections / Q000276:immunology* / Q000517:prevention & control; D005260:Female; D006386:Hemagglutination Tests; D007109:Immunity / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D011817:Rabbits; D016038:Skin Transplantation; D013552:Swine; D013950:Thymus Gland; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000863:Antacids; D000961:Antilymphocyte Serum; D001428:Bacterial Vaccines; D007166:Immunosuppressive Agents